Searchicon: search

Enter the NXT-era of FeLV protection

Nobivac® NXT FeLV delivers long-lasting protection that is both adjuvant-free and preservative-free for robust efficacy with demonstrated safety.

Enter the NXT-era of FeLV protection

Nobivac® NXT FeLV delivers long-lasting protection that is both adjuvant-free and preservative-free for robust efficacy with demonstrated safety.

Product Description

The first and only FeLV vaccine built on RNA particle technology.

  • Minimum age: 8 weeks of age
  • Volume: 0.5 mL
  • Administration: Subcutaneous
  • Duration of immunity: 2 years†
  • Presentation: 25 x 1 dose
View label

†For primary immunization, administer 1 dose (0.5mL) subcutaneously as early as 8 weeks of age, followed by a second dose administered 3 to 4 weeks later.

Always read the label to determine whether the product is suitable for the animal to be vaccinated. Vaccination may not fully protect every animal that gets vaccinated.

Transform how you protect your patients

No more than what’s necessary in every vial

0.5-mL dose. Adjuvant-free.

Preservative-free.

Multilayered immune system activation

RNA particle technology creates powerful antibody and cell-mediated immune responses.

Performance without compromise

Robust and reliable efficacy, with demonstrated safety.

Let’s leap forward into the NXT Generation

AVP

1782750

WDDC

144119

VP

2401940

CDMV

129688

Because cats are more than just pets – they’re family

We help veterinary professionals and pet owners give back to the animals that bring them joy and companionship.

Browse our feline product portfolio

NOBIVAC® is a registered trademark of Intervet International B.V., used under license.